Synarc To Present At The UBS Global Healthcare Services Conference

SAN FRANCISCO, Calif. – February 8th, 2007 — Synarc today announced that Gary Velasquez, President and CEO, is scheduled to speak at the UBS Global Healthcare Services Conference at the Grand Hyatt Hotel, New York, New York. Synarc’s presentation is planned for Tuesday, February 13, 2007 at 1:00 p.m. (Eastern Time).

Synarc is the world's leading pharmaceutical service organization dedicated exclusively to global clinical trials providing imaging, Biochemical markers, and study participant recruitment services. Synarc has contributed to the approval of more leading compounds, across a broad spectrum of therapeutic areas, than any other central imaging provider. Synarc has sixteen offices around the world and currently manages over 200 clinical trials involving more than 200,000 patients.

Synarc's in-house radiologists and scientists are leading authorities in the use of medical imaging and Biochemical markers in drug development, and have pioneered many methods currently used in clinical trials. Our services include, study participant recruitment in emerging global markets, specializing in rapid enrollment with minimal dropout rates. We integrate all aspects of the design and execution of early to late phase clinical studies, including the centralized analysis of both standard and esoteric medical imaging and Biochemical markers. Synarc’s services span the spectrum of diseases including; Arthritis, Osteoporosis, Neurology, Orthopedics, Oncology and Cardiovascular disease.  To learn more about our growing organization, visit our web site at: www.synarc.com.

#  #  #

Media Contact:
Victoria Swanson
415 817-7912
victoria.swanson@synarc.com